Digitisation | December 31, 2023
Adani and Sirius form JV to digitally transform India's digital economy
Sirius JV will be owned 51% by Sirius and 49% by Adani
Sirius JV will be owned 51% by Sirius and 49% by Adani
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
Lack of technology transfer stands out as a formidable barrier
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
Subscribe To Our Newsletter & Stay Updated
